Abstract
528 Vol 348 • August 24, 1996 J Med 1994; 330: 438–39. 14 Saran BR, Maguire AM, Nichols C, et al. Hypopyon uveitis in patients with acquired immunodeficiency syndrome treated for systemic Mycobacterium avium complex infection with rifabutin. Arch Ophthalmol 1994; 112: 1159–65. 15 Rosenberg PR, Uliss AE, Friedland GH, et al. Acquired immunodeficiency syndrome: ophthalmic manifestations in ambulatory patients. Ophthalmology 1983; 90: 874–78. 16 Freeman WR, Lerner CW, Mines JA, et al. A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol 1984; 97: 133–42. 17 Humphry RC, Weber JN, Marsh RJ. Ophthalmic findings in a group of ambulatory patients infected by human immunodeficiency virus (HIV): a prospective study. Br J Ophthalmol 1987; 71: 565–69. 18 Rummelt V, Rummelt C, Jahn G, et al. Triple retinal infection with human immunodeficiency virus type 1, cytomegalovirus, and herpes simplex virus type 1: light and electron microscopy, immunohistochemistry and in situ hybridization. Ophthalmology 1994; 101: 270–79. 19 Studies of Ocular Complications of AIDS Research Group. Mortality in patients with the acquired immunodeficiency syndrome treated with either foscarnet or ganciclovir for cytomegalovirus retinitis. N Engl J Med 1992; 326: 213–20. 20 Heinemann M-H. Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy. Arch Ophthalmol 1989; 107: 1767–72. 21 Anand R, Nightingale SD, Fish RH, et al. Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol 1993; 111: 223–27. 22 Kupperman BD, Gordon JF, the Ganciclovir Implant Study Group. A multicenter study to evaluate the safety and efficacy of an intravitreal ganciclovir implant in patients with CMV retinitis. Invest Ophthalmol Vis Sci 1996; 37: S898. 23 Taskintuna I, Rahhal FM, Arevalo JF, et al. Low dose intravitreal HPMPC (Cidofovir) therapy for CMV retinitis in patients with AIDS. Invest Ophthalmol Vis Sci 1996; 37: S669. 24 Schimkat M, Althaus C, Sundmacher R. Prophylactic argon-laser coagulation for rhegmatogenous retinal detachment in AIDS patients with cytomegalovirus retinitis. Invest Ophthalmol Vis Sci 1996; 37: S370. 25 Katz DA, Berger JR. Neurosyphilis in acquired immunodeficiency syndrome. Arch Neurol 1989; 46: 895–98. 26 McLeish WM, Pulido JS, Holland S, et al. The ocular manifestations of syphilis in the human immunodeficiency virus type 1-infected host. Ophthalmology 1990; 97: 196–203. 27 Keane JR. Neuro-ophthalmologic signs of AIDS: 50 patients. Neurology 1991; 97: 196–203. 28 Hamed LM, Schatz NJ, Galetta SL. Brainstem ocular motility and AIDS. Am J Ophthalmol 1988; 106: 437–42. 29 Friedman DI. Neuro-ophthalmic manifestations of human immunodeficiency virus infection. Neurol Clin 1991; 9: 55–72. 30 Dennehy PJ, Warman R, Flynn JT, et al. Ocular manifestations in pediatric patients with acquired immunodeficiency syndrome. Arch Ophthalmol 1989; 107: 978–82.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
